These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6403950)

  • 1. Bromocriptine promotes recovery of self-stimulation in 6-hydroxydopamine-lesioned rats.
    Carey RJ
    Pharmacol Biochem Behav; 1983 Feb; 18(2):273-6. PubMed ID: 6403950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral 6-hydroxydopamine lesions of dopamine neurons produce bilateral self-stimulation deficits.
    Carey RJ
    Behav Brain Res; 1982 Oct; 6(2):101-14. PubMed ID: 6814462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G; Jaton AL; Vigouret JM
    Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala.
    Deminière JM; Taghzouti K; Tassin JP; Le Moal M; Simon H
    Psychopharmacology (Berl); 1988; 94(2):232-6. PubMed ID: 3127850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateralized decrease in self-stimulation induced by haloperidol in rats with unilateral 6-hydroxydopamine lesions.
    Carey RJ
    Behav Brain Res; 1985 Dec; 18(3):215-22. PubMed ID: 3937541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of ibotenic acid and 6-hydroxydopamine lesions of the lateral hypothalamus on intracranial self-stimulation and stimulation-induced locomotion.
    Velley L; Verney C; Kempf E; Berger B
    Neuroscience; 1988 May; 25(2):595-603. PubMed ID: 3135510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine-induced facilitation of intracranial self-stimulation following dopamine denervation of the nucleus accumbens.
    Strecker RE; Roberts DC; Koob GF
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1015-8. PubMed ID: 6817349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 14. A role for dopamine in the psychopharmacology of electrical self-stimulation.
    Cooper BR; Breese GR
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):63-70. PubMed ID: 1233385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased intracranial self-stimulation after neuroleptics or 6-hydroxydopamine: evidence for mediation by motor deficits rather than by reduced reward.
    Fibiger HC; Carter DA; Phillips AG
    Psychopharmacology (Berl); 1976 May; 47(1):21-7. PubMed ID: 959465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
    Cooper BR; Cott JM; Breese GR
    Psychopharmacologia; 1974 Jul; 37(3):235-48. PubMed ID: 4851731
    [No Abstract]   [Full Text] [Related]  

  • 18. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
    French ED; Vantini G
    Psychopharmacology (Berl); 1984; 82(1-2):83-8. PubMed ID: 6141586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
    Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
    Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.